G. Walmsley Graham is Director at Akero Therapeutics, Inc. (AKRO). They have made 16 open-market trades across 3 companies since 2020, most recently 2025-12-09.
CIK 0001777517
13 open-market purchases totalling $118.8M since 2020, against 3 sales. Across 13 scored buys the stock is down 4.5% at ninety days, and 7.9 points behind the S&P over the same stretch.
13 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 54% | 46% | 38% |
| Avg Move | +0.4% | +2.5% | -4.5% |
| Alpha | +0.7% | +1.5% | -7.9% |
| Scored | 13 | 13 | 13 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AKRO | BUY | 2025-03-25 | 2025-03-27 | $44.00 | $15.4M | -25.0% | -7.1% | +21.3% |
| AKRO | BUY | 2025-01-30 | 2025-02-07 | $48.00 | $9.6M | -9.4% | -25.3% | -24.0% |
| OLMA | BUY | 2024-12-17 | 2024-12-17 | $6.75 | $4.7M | -11.8% | -17.0% | -30.0% |
| OLMA | SELL | 2024-12-17 | 2024-12-17 | $6.75 | $9.5M | -11.8% | -17.0% | -30.0% |
| OLMA | BUY | 2024-12-13 | 2024-12-18 | $6.75 | $9.5M | -1.5% | -4.4% | -30.1% |
| OLMA | SELL | 2024-12-13 | 2024-12-18 | $6.75 | $4.7M | -1.5% | -4.4% | -30.1% |
| OLMA | SELL | 2024-06-04 | 2024-06-06 | $14.85 | $17.4M | -6.2% | -13.8% | -10.5% |
| AKRO | BUY | 2023-12-08 | 2023-12-11 | $19.83 | $3.0M | +12.8% | +17.9% | +48.1% |
| AKRO | BUY | 2023-11-30 | 2023-12-05 | $16.95 | $3.4M | +23.8% | +23.3% | +67.9% |
| AKRO | BUY | 2023-09-19 | 2023-05-23 | $— | — | +17.1% | +17.1% | +8.1% |
| OLMA | BUY | 2023-09-12 | 2023-12-18 | $10.46 | $12.3M | +2.6% | -17.7% | -18.9% |
| AKRO | BUY | 2023-08-08 | 2023-08-10 | $42.06 | $1.1M | +3.1% | +7.1% | -67.3% |
| AKRO | BUY | 2023-07-28 | 2023-08-01 | $42.95 | $2.4M | +3.6% | +8.2% | -74.5% |
| AKRO | BUY | 2022-09-19 | 2023-06-15 | $29.69 | $15.4M | -19.5% | -20.7% | -10.8% |
| ALXO | BUY | 2020-12-14 | 2020-12-15 | $76.00 | $1.5M | -0.3% | -1.2% | -8.6% |
| OLMA | BUY | 2020-11-23 | 2020-11-23 | $19.00 | $22.0M | -8.1% | -6.7% | -3.3% |
| ALXO | BUY | 2020-07-21 | 2020-07-21 | $19.00 | $18.5M | +5.8% | +41.6% | +34.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.